SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
NOV Inc. (NOV) trades at a trailing P/E of 49.4, forward P/E of 19.5. Trailing earnings yield is 2.02%, forward earnings yield 5.14%. PEG 0.13 (Peter Lynch undervalued ≤1.0). Graham Number is $12.48.
Criteria proven by this page:
- VALUE (39/100, Fail) — trailing P/E is well above the S&P 500 average of ~25, suggesting a premium valuation (P/E 49.4).
- Forward P/E 19.5 (down from trailing 49.4) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 0.13 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 2.02% — below bond yields — investors are paying a premium for expected growth rather than current earnings. Forward yield improves to 5.14% as earnings recover.
- Analyst consensus target $18.33 (-4% downside) — slight downside risk — the market may be ahead of analyst expectations.
Overall SharesGrow Score: 59/100 with 3/7 criteria passed.
SharesGrow 7-Criteria Score
✗
VALUE
39/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
83/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — NOV
Valuation Multiples
P/E (TTM)49.4
Forward P/E19.5
PEG Ratio0.13
Forward PEG0.13
P/B Ratio1.14
P/S Ratio0.82
EV/EBITDA9.7
Per Share Data
EPS (TTM)$0.40
Forward EPS (Est.)$0.98
Book Value / Share$17.37
Revenue / Share$24.02
FCF / Share$2.41
Yields & Fair Value
Earnings Yield2.02%
Forward Earnings Yield5.14%
Dividend Yield2.67%
Graham Number$12.48
SharesGrow IV$151.07 (+690.9%)
Analyst Target$18.33 (-4%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2016 |
-5.8 |
-0.03 |
1.01 |
1.94 |
1.63% |
| 2017 |
-57.2 |
0.63 |
0.96 |
1.86 |
0.56% |
| 2018 |
-313.4 |
3.60 |
0.70 |
1.15 |
0.78% |
| 2019 |
-1.6 |
0.00 |
1.23 |
1.13 |
0.80% |
| 2020 |
-2.1 |
0.04 |
1.01 |
0.87 |
0.36% |
| 2021 |
-20.9 |
0.23 |
1.05 |
0.95 |
0.38% |
| 2022 |
52.6 |
-0.33 |
1.60 |
1.13 |
0.96% |
| 2023 |
8.0 |
0.02 |
1.29 |
0.93 |
0.99% |
| 2024 |
9.0 |
-0.25 |
0.90 |
0.65 |
1.89% |
| 2025 |
40.1 |
-0.53 |
0.93 |
0.66 |
3.27% |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$-6.41 |
$7.25B |
$-2.41B |
-33.3% |
| 2017 |
$-0.63 |
$7.3B |
$-237M |
-3.2% |
| 2018 |
$-0.08 |
$8.45B |
$-31M |
-0.4% |
| 2019 |
$-15.95 |
$8.48B |
$-6.09B |
-71.9% |
| 2020 |
$-6.61 |
$6.09B |
$-2.54B |
-41.7% |
| 2021 |
$-0.63 |
$5.52B |
$-245M |
-4.4% |
| 2022 |
$0.39 |
$7.24B |
$155M |
2.1% |
| 2023 |
$2.50 |
$8.58B |
$993M |
11.6% |
| 2024 |
$1.60 |
$8.87B |
$635M |
7.2% |
| 2025 |
$0.39 |
$8.74B |
$145M |
1.7% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$0.99 |
$0.34 – $1.16 |
$8.64B |
$8.38B – $8.85B |
12 |
| 2027 |
$1.28 |
$1.12 – $1.55 |
$8.91B |
$8.54B – $9.22B |
12 |
| 2028 |
$1.58 |
$1.36 – $1.91 |
$9.29B |
$9.27B – $9.31B |
4 |
| 2029 |
$1.79 |
$1.72 – $1.85 |
$9.45B |
$9.17B – $9.71B |
2 |
| 2030 |
$1.88 |
$1.81 – $1.95 |
$9.53B |
$9.24B – $9.79B |
2 |
